The majority of variants identified by genome--wide association studies (GWAS) reside in the noncoding genome, where they affect regulatory elements including transcriptional enhancers.
significant or almost significant variants near each tagging variant. This set is pruned by linkage disequilibrium (LD) structure using PLINK [18] , where representative subsets of variants within each LD block are chosen such that subjecting them to LD expansion recaptures the other variants in the LD block. This analysis uses LD block data in a user--defined population (European, African, or Asian) from the 1,000 Genomes Project [19] . These LD block--tagging variants are re--expanded into full LD blocks, and these expanded sets are used for all further analysis to maximize the chance of finding the truly causal genetic variants underlying each association signal. This expansion approach provides a comprehensive set of putatively causal variants by taking full GWAS summary statistics as well as LD structure into account. If full summary statistics are not available, INFERNO can directly expand the top tag GWAS variants into LD blocks.
Annotation of expanded variant sets with transcriptional regulatory elements
To identify noncoding genetic variants, INFERNO quantifies the proportion of variants overlapping messenger RNA (mRNA) promoters, exons (i.e. coding variants), introns, 5' untranslated region (UTR) exons and introns, 3' UTR exons and introns, and RepeatMasker genomic repeats [20] including LINE and SINE elements. Any variant outside all of these regions is classified as intergenic.
Next, each variant is overlapped with two complementary enhancer data sources. The first are sites of enhancer RNA (eRNA) transcription, which reflects enhancer activity [21] , as assayed by cap analysis of gene expression (CAGE--seq) data generated by the FANTOM5 consortium across 112 tissue and cell type groupings [7] . The second is enhancer states defined by ChromHMM [22] using combinatorial epigenomic states measured by chromatin immunoprecipitation and sequencing (ChIP--seq) of 5 histone modifications, which mark active enhancers in a stereotypical pattern [23, 24] , across 127 tissues and cell types generated by the Roadmap Epigenomics Project [8] and by the Encyclopedia of DNA Elements (ENCODE) project [9, 25] . In the Roadmap analysis, variants are overlapped with a total of 15 ChromHMM states including 3 types of enhancer states, sites of genic transcription, repressed regions, and active promoters, another type of transcriptional regulatory element that may harbor causal variants underlying an association signal.
In addition to overlapping variants with functional genomics annotations across tissues, INFERNO includes a sequence--based analysis to find variants affecting transcription factor binding sites (TFBSs) identified by the HOMER tool [26] (see Methods). INFERNO uses positional weight matrices (PWMs) to compute the difference in the log--odds binding probability of each affected TFBS between the reference and alternate alleles of the overlapping genetic variant (∆PWM score) in order to identify genetic variants that either increase or decrease TFBS strength.
Tissue categorization of annotations and integrative analysis
Combining information across complementary sources of functional genomics data enables the comparison of evidence from independent experiments to improve sensitivity and robustness. However, it is not possible to directly compare results across the three consortia analyzed by INFERNO (FANTOM5, Roadmap, and GTEx) because each assayed different tissue types and cell lines at different levels of biological complexity. To integrate evidence from these disparate data sources, we designed a tissue classification scheme that grouped individual samples from each data source into one of 32 tissue categories (Supplementary Tables 1--3, Supplementary   Figure 1 ). Datasets from both the GTEx and FANTOM5 consortia were grouped into high--level categories using the UBERON and CL ontologies for tissues and cell types, respectively [27, 28] .
This integrative categorization provides a high--level view of the affected tissue contexts across consortia, allowing for easy identification of the tissue contexts harboring noncoding elements affected by variants within each GWAS tag region.
Background sampling for enrichment of enhancer overlaps
Due to the widespread regulatory activity in the noncoding genome [9] , selecting a large set of genetic variants in an LD block and overlapping them with hundreds of functional measurements may yield many overlaps simply by chance. To quantify the significance of enhancer overlap enrichment, INFERNO includes a statistical sampling approach to define empirical p--values for the enrichment of overlaps for each pair of annotations a and tissue category t within individual GWAS tag regions as well as across all tag regions (e.g. a = FANTOM5 enhancers, t = brain, see Methods).
eQTL co--localization analysis
Current noncoding genetic variation annotation methods can identify functional variants and affected regulatory elements, and in some cases provide a hypothesis--free characterization of the relevant tissue context [29] , but do not fully characterize the affected target genes. These methods either assume that the nearest gene is the affected transcript or directly overlap variants with eQTLs, including HaploReg, which directly overlaps variants with eQTL signals from 14 sources. However, the closest gene is typically not the target of transcriptional regulatory elements [5] , and direct overlap of variants with eQTL signals is biased by genomic LD structures, where an eQTL association signal may be spread across a haplotype block so that the measured variant is not the causal regulatory variant.
When summary statistics are not available, INFERNO performs direct overlap with eQTL signals across 44 tissues from the Genotype--Tissue Expression (GTEx) project [15] . However, if summary statistics are available, INFERNO performs co--localization analysis using the COLOC method to control for bias from LD structures [16] . This model uses a Bayesian statistical model to calculate posterior probabilities for different causality relationships between GWAS and tissue--specific eQTL signals. The most relevant hypothesis from the COLOC output for INFERNO is H 4 , that there is a shared causal variant underlying both the eQTL signal and the GWAS disease signal. INFERNO performs co--localization analysis comparing all GWAS signals within 500kb of each tag variant with eQTL signals across all 44 GTEx tissues (Methods). Strongly co-localized signals are defined as those with P(H 4 ) ≥ 0.5. COLOC also reports the probability of any individual variant being the shared causal variant, measured by the Approximate Bayes Factor (ABF). For further analysis of putatively causal variants, INFERNO defines sets of variants accounting for at least half of the cumulative ABF distribution at each strongly co--localized signal. This allows for the sensitive detection of truly co--localized signals to identify causal variants, the target genes they affect, and the tissue context of the regulation.
Integrative analysis of co--localized eQTLs with annotations
To integrate the results between the enhancer and eQTL analyses, INFERNO uses the tissue categorizations of the FANTOM5, Roadmap, and GTEx datasets to stratify variants in the ABF-expanded sets underlying a co--localized signal by whether they affect a TFBS, overlap a FANTOM5 or Roadmap enhancer, and whether the enhancer came from the same tissue category as the eQTL signal. Variants in the ABF--expanded sets underlying a strongly co-localized eQTL signal overlapping enhancers from a concordant tissue class are prioritized if they also overlap a TFBS and/or have a high individual ABF value (Methods). This enables the identification of a small number of causal genetic signals and affected target genes supported by a variety of diverse functional genomics data sources all implicating the same tissue category. This integration of diverse data types spanning epigenomic marks, enhancer activity, transcription factor motifs, and eQTL signals provides a useful tool to identify causal variants, 
Correlation--based lncRNA target identification
Finding a GTEx eQTL target gene supported by concordant enhancer support may be only the first step to understanding the affected regulatory mechanism underlying a genetic association signal, because the GTEx eQTL data also includes long noncoding RNA (lncRNA) signals, which can act as transcriptional regulatory elements for other genes [30] . Although tools for lncRNA target prediction exist, lncRNA targeting mechanisms are not fully characterized, so INFERNO takes an unbiased approach to finding their targets. RNA sequencing--based expression vectors of all genes in the genome including lncRNAs across all samples and tissues from GTEx are correlated with the expression vector of a lncRNA of interest. Then, genes with correlation values meeting user--specified threshold on Spearman and Pearson correlations (Methods) are considered to be putative lncRNA target genes, in line with previous approaches to lncRNA target identification [31] . This analysis is done automatically within INFERNO after the co-localization analysis is complete, and lists of lncRNA targets are provided for users to perform pathway analysis to characterize the affected biological processes downstream of the lncRNA signal, including lists of targets split by the GTEx tissue and tissue category of the lncRNA signal.
Application to schizophrenia GWAS
To demonstrate INFERNO's utility, we analyzed a GWAS dataset for schizophrenia from the Psychiatric Genomics Consortium with 108 LD--independent signals (n = 36,989 cases, 113,075 controls, [17] ). P--value expansion of variants within an order of significance magnitude of the top variants yielded 3,778 unique variants, which were LD pruned down to 268 independent variants. LD re--expansion with a threshold of R 2 >= 0.7 in the European population of 1,000 genomes then yielded 8,371 unique variants (Figure 2a ). Genomic partition analysis of these variants supported their noncoding function, as only 79 (0.8%) of these variants were located in messenger RNA (mRNA) exons, with the majority in mRNA introns (3,050), repeat elements (2,819), or outside of any annotations (2,087) ( Figure 2b ). Overlapping these variants with enhancer annotations found widespread enhancer signals in the Roadmap data, with 4,127 (49%) variants overlapping a ChromHMM enhancer state in at least one tissue ( Figure 2c ). The FANTOM5 overlaps were limited due to the more conservative nature of the eRNA measurements, with 196 (2.3%) variants overlapping a FANTOM5 enhancer in at least one tissue. Finally, overlap with HOMER TFBSs found that 3,821 (45%) unique variants overlapped TFBSs for 233 unique transcription factors for a total of 10,798 variant-TFBS overlaps. The majority (8,976) of these overlaps lowered the predicted binding strength ( Figure 2d ).
We observed no significant enrichments of enhancer overlaps in any tissue category when considering all the tag regions together. However, four individual tag regions (rs2239063 (12p13.33), rs2693698 (14q32.2), rs6704641 (2q33.1), and rs4330281 (3p24.3)) harbored significant enrichments of enhancers in categories related to immunity (blood, adipose cells, tonsils, immune organ) and stem cells (including iPSC and placenta) ( Supplementary Figure 2 ).
The enrichment in the immune system is of particular interest given the strong epidemiologic and molecular genetic evidence of immune dysfunction in schizophrenia [32, 33] .
Next, 99,354 co--localization tests (COLOC) were performed across the 108 tag regions, identifying 969 unique tissue--target gene eQTL signals across all 44 GTEx tissues and 300 unique genes (including 57 lncRNAs from 34 tissues) that were strongly co--localized with schizophrenia GWAS signals (Supplementary Table 4 , Supplementary Figure 3 ). To characterize the downstream biological processes affected by these variants, we performed pathway analysis on the 300 co--localized target genes using the WebGestalt tool [34, 35] , but this did not yield any significant enrichments.
Cross--reference of the significantly enriched tag regions with the COLOC results found that the rs2239063 region harbored co--localized eQTLs for CACNA1C in cerebellum and cerebellar hemisphere of brain ( Supplementary Table 4 ). Variants in the ABF--expanded sets underlying these signals had concordant enhancer support from Roadmap enhancers in several data sources including thymus, hippocampus, and fetal brain as well as TFBS disruptions for the RFX5 and RFX1 transcription factors. These are two members out of 5 in the mammalian regulatory factor X (RFX) family of TFs, which play a key role in regulation of the immune response [36] .
The brain microglial immune response plays a role in schizophrenia etiology and CACNA1C is a known schizophrenia--related gene [37, 38] , supporting the utility and reproducibility of INFERNO results.
As an alternative approach for prioritizing the strongest results in the COLOC analysis, we identified 5 regions harboring co--localized eQTL and GWAS signals supported by variants with individually high ABFs as well as enhancer overlaps from the same tissue category: rs4766428 (12q24.11), rs4648845 (1p36.32), rs12826178/rs324017 (overlapping regions in 12q13.3), rs56205728 (15q15.1), and rs4702 (15q26.1) (Figure 3a , Supplementary Table 4 ).
In the 12q24 region around rs4766428, rs4766428 itself was prioritized as having high ABF underlying 12 distinct eQTL signals including for C12orf76 and VPS29 in the brain category and TCTN1 in the nerve tissue category (Figure 3b ). Note that this variant lies in an intron of ATP2A2 but does not target that gene. These three genes are all involved in transmembrane cellular processes: C12orf76 is an unannotated transcript associated with the 'ion channel activity' GO pathway [39] , VPS29 is part of a group of vacuolar sorting proteins [40] , and TCTN1 encodes a family of secreted transmembrane proteins involved in ciliopathies and several cancer types [41] . This variant also disrupts binding sites for ERRA, PPARg, and RXR (∆PWM = --1.95, --1.84, --2.06, respectively). ERRA, also known as estrogen related receptor alpha, is an orphan nuclear receptor with no known ligand that is known to play a central role in regulating energy homeostasis and metabolism [42] , which is disrupted in schizophrenia [43] . PPARg is a member of the peroxisome proliferator--activated receptor subfamily of transcription factors which are involved in adipocyte differentiation [44] in addition to having anti--inflammatory properties [45] . Furthermore, these factors form heterodimers with retinoid X receptors (RXR), and the retinoid pathway has been suggested as a potential causal factor for schizophrenia [46, 47] . Of particular relevance is the ChromHMM enhancer overlap in brain dorsolateral prefrontal cortex (highlighted with red box in Figure 3b ), the most relevant brain region in schizophrenia [48] .
In the 1p36 region around rs4648845, a single variant, rs4592207, was found to underlie a pancreatic eQTL signal for the lncRNA RP4--758J18.10 with high ABF. This variant also overlaps an RFX5 binding site as well as one for STAT3, a member of the important signal transducer and activator of transcription (STAT) family of proteins. This protein family is associated with many human diseases, and drugs to inhibit STAT3 phosphorylation are in clinical trials for the treatment of schizophrenia as well as several other diseases including Alzheimer's disease, several cancer types, and type 2 diabetes [49] .
In the 12q13 region around rs12826178, this analysis prioritized rs12826178 itself with high ABF underlying a blood eQTL signal for TSPAN31, another transmembrane protein also known as SAS that is amplified in human sarcomas [50] . This variant overlapped Roadmap enhancers from 9 tissues including several immune cells in the blood category but did not overlap any TFBSs. The variant rs12826178 was also prioritized in the nearby region around rs324017 for the same eQTL signal, but was not part of the LD expanded set in that region.
In the 15q15 region around rs56205728, the variant itself was found to underlie 4 eQTL signals with high ABF, including BUB1B in brain cerebellar hemisphere and cerebellum and PAK6 and PLCB2 in skeletal muscle. This variant overlaps Roadmap enhancers from 28 data sources including astrocytes and several immune cell lines. BUB1B is a mitotic checkpoint serine/threonine kinase, and is differentially overexpressed in both schizophrenia and bipolar disorder brains [51] . PAK6 is another serine/threonine kinase that is a member of the p21-activated kinase (PAK) family. PAK inhibitors ameliorate dendritic spine deterioration associated with schizophrenia [52] , and disruption of this gene in mice leads to learning and locomotion deficits [53] . PLCB2 is a phosphodiesterase that is involved in innate immunity [54] .
Finally, in the 15q26 region around rs4702, rs4702 is the prioritized variant underlying four eQTL signals, for FES in subcutaneous adipose and pancreas, SLCO3A1 in transformed fibroblasts, and FURIN in esophagus mucosa. This variant overlaps enhancers from 46 Roadmap datasets, and although the tissues do not seem to be directly relevant to schizophrenia, there is experimental evidence that FURIN is involved in neurodevelopmental processes that may be affected in schizophrenia [55] .
Using the top 108 LD--independent signals as input, HaploReg detected almost none of the top results identified by INFERNO. In the rs2239063 region, no eQTLs for CACNA1C were detected.
In the rs4766428 region, HaploReg did not identify any brain signals for VPS29 and did not identify any eQTL signals at all for C12orf76 and TCTN1. In the rs4648845 region, the variant we prioritized, rs4592207, is not part of the LD--expanded block analyzed by HaploReg. In the rs1286178 region, HaploReg did not detect any eQTL signal for rs1286178. In the rs56205728 region, HaploReg did not identify the brain signals for BUB1B or the PAK6 signal, although it did detect a PLCB2 eQTL, albeit in lymphocytes and lung rather than the skeletal muscle signal INFERNO prioritized. Finally, in the rs4702 region, HaploReg detected the FES signals in pancreas but not subcutaneous adipose, detected the FURIN signal in esophagus mucosa, and missed the SLCO3A1 fibroblast signal, although it identified additional FES signals in fibroblasts and thyroid that INFERNO did not identify as strongly co--localized signals (P(H 4 ) = 0.08 and 0.40, respectively).
Next, we performed correlation--based target identification for the lncRNAs targeted by co-localized eQTL signals, which identified 6,005 unique genes targeted by 46 unique lncRNAs from 33 tissues and 15 tissue classes ( Supplementary Figure 4) . We first performed pathway analysis on all 6,005 genes targeted by these lncRNAs. This found significant enrichments in several schizophrenia--related pathways (Supplementary Table 5 ) including RNA splicing [56] , phosphatidylinositol signaling [57] , Th1 and Th2 cell differentiation [58] , T cell receptor signaling [59] , and RNA transport [60] .
To refine our understanding of the downstream effects of these lncRNAs, we split the lists of target genes by which tissue category the lncRNA eQTL signal came from and performed pathway analysis separately in each category ( Figure 4 ). This identified tissue--specific pathway effects in pathways known to be related to schizophrenia such as the MAPK signaling pathway (KEGG pathway ID hsa04010) [61] in the blood category as well as pathways that were enriched across several contexts, notably implicating the spliceosome (hsa03040) [56] , which was enriched in 10 categories including blood and brain. Another intriguing signal was the enrichment of the Herpes simplex infection (hsa05168) pathway in 8 categories, also including blood and brain. Maternal Herpes simplex virus (HSV) infection may lead to increased risk of schizophrenia in their offspring [62] and HSV exposure may exacerbate cognitive function impairment in schizophrenic patients [63] . Thus, the lncRNA target identification performed by INFERNO can identify biologically relevant genes and pathways downstream of lncRNA perturbations by genetic variants.
Web server and tool availability
We provide a web server for INFERNO analyses that accepts the top variants from any given GWAS and performs the annotation overlap analysis including directly overlapping variants with GTEx eQTL data [64] . To run the computationally intensive enhancer sampling, eQTL co-localization, and lncRNA correlation analyses, INFERNO is also available as an open source pipeline [65] .
Discussion
INFERNO provides a sensitive hypothesis generation method for identifying functional genetic variants underlying genetic association signals and characterizing their tissue--specific effects on regulatory elements, target genes, and downstream biological processes. The schizophrenia analysis demonstrated that INFERNO picks up many signals that converge to common tissue contexts and pathways when sufficient genetic loci are available. However, while the diversity of functional genomic data and tissue contexts analyzed by INFERNO allows it to identify functional variants, regulatory elements, and target genes underlying GWAS association signals, this broad range of data sources also means that our algorithm may pick up more general regulatory mechanisms not directly related to the phenotype of interest, and these "hitchhikers" could obfuscate the truly causal processes. This is likely to be a characteristic of complex traits in general. Another factor that affects the specificity of INFERNO results is the currently limited availability of functional genomics annotation data, which are measured in normal tissues that do not reflect the disease state for a given GWAS signal and may not be exact matches for the relevant tissue context for a given trait. Thus, INFERNO is best used as a powerful tool to prioritize biological processes and tissue contexts in an unbiased and systematic fashion for functional follow--up studies to prove the causality of the prioritized signals and their relevance to the phenotype of interest.
INFERNO improves on existing noncoding annotation methods for GWAS signals, the most comparable of which is HaploReg [14] . HaploReg expands GWAS variants by LD structure only, missing many of the candidate variants INFERNO identifies using summary statistic--based expansion, and reports direct annotation overlaps with Roadmap but not FANTOM5 enhancer annotations. Additionally, it lacks a tissue classification framework to integrate information across disparate annotation sources. HaploReg provides an enhancer enrichment score by calculating the background frequencies of enhancer overlap in each cell type for all unique GWAS loci and all 1,000 Genomes common variants and comparing these frequencies to those for a query list of variants using a binomial test. This approach ignores LD structure and does not match variants by any characteristics. INFERNO provides a more sensitive statistical method for quantifying the tissue--specific significance of annotation overlaps in a GWAS signal accounting for LD structure and other genomic characteristics. Furthermore, INFERNO allows for the calculation of enrichments both within and across tag regions, and the tissue classification approach enables the scoring of enrichments supported by disparate data sources. INFERNO also performs a more sensitive eQTL analysis by applying a Bayesian model to identify truly co--localized signals between GWAS and eQTL data, and additionally performs target identification for lncRNA targets identified by this algorithm.
Application of INFERNO to schizophrenia GWAS data identified significant overlaps of enhancers in immune--and brain--related tissue categories and eQTL signals from the same categories targeting known schizophrenia genes. This analysis identified putatively functional variants in 6 tag regions and also identified tissue--specific lncRNA signals targeting several biological processes known to be related to schizophrenia including the MAPK signaling pathway, spliceosome, and Herpes simplex infection.
INFERNO is limited by currently available functional genomics datasets, and will continue to increase in power as functional datasets are generated in more tissue and cell types and as genomics technology continues to be refined and improved. Another movement in the field is to consider structural variation and copy number variants in addition to the single nucleotide variants that INFERNO currently analyzes, and as more of these data are generated INFERNO will be updated to allow for the analysis of these signals in the noncoding genome.
Conclusion
In this manuscript, we present the INFERNO (INFERring the molecular mechanisms of NOncoding genetic variants) tool for characterizing functional variants underlying GWAS association signals as well as the regulatory mechanisms, tissue contexts, target genes, and biological processes they affect. This tool integrates information across hundreds of functional genomics datasets to provide a data--driven, hypothesis--free approach for detailed characterization and identification of noncoding genetic variants underlying genetic association signals to provide biologically interpretable results. This characterization of the relevant tissue contexts and biological pathways underlying disease risk can improve the mechanistic understanding of disease risk as well as identify candidate therapeutic targets for future pharmacological interventions.
INFERNO provides the most comprehensive and unbiased tool to identify causal noncoding variants disrupting enhancers and the downstream effects of these disruptions including the relevant tissue context and affected target genes and pathways. We provide a web server (http://inferno.lisanwanglab.org) that takes in top GWAS variants, expands them into LD blocks, and annotates them with functional genomics data and direct eQTL overlap. We also provide open source code [65] for the full pipeline that runs on full GWAS summary statistics and performs p--value as well as LD expansion, sampling for functional enrichment, GTEx eQTL co-localization, and lncRNA target identification in addition to the annotation overlaps provided by the web server.
Methods

P--value and LD expansion of IGAP variants
Given GWAS summary statistics and a set of user--defined top variants, INFERNO first computes the sets of all variants i within 500 kb of each tagging variant such that # ≤ * ' where # is the p--value assigned to variant i, ' is the p--value of the tagging variant, and m is the user-defined multiplicative constant, 10 by default for one order of magnitude. These sets are pruned by linkage disequilibrium using PLINK v1.90b2i 64--bit [18] with the parameters ----vcf for the input file and '----indep--pairwise 500kb 1 0.7' (within 500,000bp and meeting a correlation threshold of R 2 >= 0.7). LD structure information is calculated using the phase 3 version 1 (May 11, 2011) of the 1,000 Genomes Project [19] . For the schizophrenia analyses in this manuscript, data from the European (EUR) population was used, but 1,000 Genomes also provides LD structure information for Africa (AFR), Asia (ASN), and the Americas (AMR) and INFERNO allows users to choose their population of interest. Then, variants are re--expanded by LD structure using the parameters ----vcf for the file containing neighboring variants and '----allow--no--sex, ----r2 with--freqs dprime ----ld--snp RSID ----ld--window 99999 ----ld--window--kb AREA ----ld--window--r2 R2', where RSID is the tag variant of interest, AREA is the LD block size threshold parameter, and R2 is the parameter defining the threshold on R 2 .
Genomic partition analysis
Variants were categorized into different functional categories using the UCSC knownGene and 
Functional annotation data download and pre--processing
FANTOM5 enhancer facet--level expression BED files, Roadmap ChromHMM BED files for the 5 core Roadmap marks (H3K4me3, H3K4me1, H3K36me3, H3K27me3, H3K9me3), HOMER TFBS annotations, and GTEx eQTL and RNAseq data were downloaded from their respective servers and further processed using the bedtools suite of tools [66] and custom awk and Python scripts.
A detailed description of the data sources and pre--processing steps is available at http://inferno.lisanwanglab.org/README.html and the full processed annotation data is available in the 'Availability of Data and Materials' section.
INFERNO pipeline implementation
The INFERNO pipeline is implemented using Python v2.7.9, R v3.2.3, and bash, and is available at https://bitbucket.org/alexamlie/inferno. The pipeline allows user--defined parameters for the 1,000 Genomes population to use, the order of magnitude cutoff for p--value expansion, the LD and distance thresholds to use for LD expansion, the size of the window around FANTOM5 loci, and whether or not to calculate ∆PWM scores. It is also flexible and can run any or all of the analysis steps including p--value and LD expansion, genomic partition analysis, overlap with 
Dataset classification into tissue categories
Building off the existing categorization of Roadmap samples and informed by the UBERON and CL ontologies [27, 28] used in the FANTOM5 facet--level classification and in GTEx, the different tissues and cell types from each data source were grouped into 32 major classes used for this analysis, and some of the data sources were further grouped into 58 secondary and 15 tertiary sub--classes (Supplementary Table 1 ).
Quantification of enhancer enrichments:
10,000 random sets of background variants matched to the input set of variants (before LD expansion) by distance to the nearest gene, minor allele frequency, and the number of variants in each tagged LD block are sampled. The variants from each background set are then expanded into their corresponding LD blocks to match the number of variants in the LD expanded input set and overlapped with the same sets of functional annotations. Then, the empirical p--value for the significance of the overlap of the input data with each functional annotation or combination of annotations a (e.g. eRNA enhancer overlap, or both eRNA enhancer overlap and eQTL overlap) in a given tissue category t is defined as (,' = +,-.,/ +,+0000
, where (,' is the number of background samples that include at least as many LD blocks overlapping the annotation a in the tissue context t as the input dataset. By default, each LD block only contributes one effective count for annotation overlap in order to correct for LD structure, but INFERNO will also report results counting each variant in an LD block separately. These empirical p--values are corrected for multiple testing using the Benjamini--Hochberg procedure [67] .
eQTL Colocalization analysis
For colocalization analysis, INFERNO uses the COLOC R package [16] to compare the eQTL signals tested in GTEx across all 44 tissues against GWAS summary statistics. For each tag region and GTEx tissue, the script identifies all the genes tested for eQTL with the tagging variant in the region, reads in the eQTL data for each gene, and performs colocalization analysis using all the GWAS variants 500,000bp on either side of the tag variant that are also found in the eQTL data. Minor allele frequencies (MAFs) can be defined by the user or can be extracted from 1,000 Genomes data using a custom preprocessing script. Then, the MAF and p--values of variants in the GWAS and eQTL datasets are used for co--localization analysis, including a user-defined sample size and case/control ratio for the GWAS of interest.
lncRNA correlation analysis
To find the target genes of each lncRNA found to have a co--localized eQTL signal, reads per kilobase per million (RPKM) values across all RNA--sequenced samples in GTEx are used. GENCODE annotations are used to identify GTEx target genes that are categorized as lncRNAs [68] , and the RPKM expression files are used to extract the expression of all genes expressed in at least one sample, including each lncRNA, for one chromosome at a time. Then the pipeline calculates the correlations of the lncRNA expression vectors against all columns (genes) of the gene expression matrix using the corr.test function from the psych R package [69] . Two correlation measures are computed: the Pearson correlation, which measures the linear relationship between two variables, and the Spearman correlation, which is a rank--based test that does not assume a linear relationship. User--defined parameters on the absolute value of both the Spearman and Pearson correlation measures, 0.5 by default, are used to identify lncRNA target genes.
Schizophrenia GWAS analysis
The full summary statistics file (scz2.snp.results.txt) and 128 top variants (scz2.rep.128.txt) for the schizophrenia analysis were obtained from the Psychiatric Genomics Consortium downloads page [70] . The top variants were parsed to remove variants on sex chromosomes and converted into INFERNO input format using awk scripts. The summary statistics were annotated with minor allele frequencies from the 1,000 genomes data using a custom script, annotate_input_variants.R, in the data_preprocessing/ section of the INFERNO code. These parsed files were then used as input to INFERNO, and the exact call used is available in the INFERNO README file [65] .
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